Sfoglia per AUTORE
SPYRIDONIDIS A
Collezione AOU Città della Salute di Torino
Items : 2
Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Nov;28(11):773.e1-773.e8. doi: 10.1016/j.jtct.2022.08.018. Epub 2022 Aug
2022
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Brissot E; Giebel S; Spyridonidis A; Sanz J; Savani BN; Canaani J; Bornhäuser M; Jindra P; Bulabois CE; Chevallier P; Vydra J; Forcade E; Bruno B; Fanin R; Blaise D; Fraccaroli A; Ciceri F; Dholaria B; Nagler A; Labopin M; Bazarbachi A; Esteve J; Mohty M;
Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP). in Bone marrow transplantation / Bone Marrow Transplant. 2022 Dec;57(12):1803-1809. doi: 10.1038/s41409-022-01830-3. Epub 2022 Sep 22
2022
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Bazarbachi A; Giebel S; Savani B; Anagnostopoulos A; Ozdogu H; Sanz J; Busca A; Zuckerman T; Mielke S; Kröger N; Hilgendorf I; Rambaldi A; Berceanu A; Potter V; Yakoub-Agha I; Salmenniemi U; Sakellari I; Gavriilaki E; Labopin M; Spyridonidis A; Nagler A; Mohty M;